Clinical Trials Browser

Has results × Triple Negative Breast Neoplasms × Lapatinib × Clear all

NCT02158507 2026-01-22

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Phase NA Completed

20 enrolled 10 charts

Triple Negative Breast Neoplasms

NCT01272141 2014-09-22

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Phase 2 Terminated

5 enrolled 3 charts

Breast Neoplasms, Triple Negative Breast Neoplasms